Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YUAN, H. T.
Right arrow Articles by WOOLF, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YUAN, H. T.
Right arrow Articles by WOOLF, A. S.
J Am Soc Nephrol 11:1055-1066, 2000
© 2000 American Society of Nephrology


REGULAR ARTICLES

Angiopoietin-2 Is a Site-Specific Factor in Differentiation of Mouse Renal Vasculature

HAI TAO YUAN*, CHITRA SURI{ddagger}, DAVID N. LANDON{dagger}, GEORGE D. YANCOPOULOS{ddagger} and ADRIAN S. WOOLF*

* Nephrourology Unit, Institute of Child Health, University College London Medical School, London, United Kingdom
{dagger} Department of Clinical Neurology, Institute of Neurology, University College London Medical School, London, United Kingdom
{ddagger} Regeneron Pharmaceuticals Inc, Tarrytown, New York.

Correspondence to Dr. Hai Tao Yuan, Nephrourology Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, United Kingdom. Phone: +44 020 7242 9789; Fax: +44 020 7916 0011; E-mail h.yuan{at}ich.ucl.ac.uk


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Abstract. Angiopoietin-1 (Ang-1) stimulates endothelial and vascular network differentiation through the Tie-2 receptor tyrosine kinase, while Ang-2 modulates this activation in embryo and tumor growth. The nephrogenic pattern of Ang-2 was documented in a mouse strain that expresses the LacZ reporter gene driven by the Ang-2 promoter. Heterozygous animals were healthy with morphologically normal kidneys, and they were examined after X-gal staining. At embryonic days 10.5 (E10.5) and E12.0, transgene expression was absent in the mesonephros and metanephros. At E14.0, expression was noted in the metanephric artery and its major branches. At E19.0 and in neonatal kidneys, expression was maintained in larger renal artery branches, extending to arcuate and smaller cortical vessels. Histologically, transgene expression was located in multiple layers of vessel wall cells, extending further from the endothelium than {alpha}-smooth muscle actin. The mesangium of immature glomeruli also expressed LacZ. In the first 3 postnatal weeks, a new pattern became evident, with intense X-gal staining in the inner stripe of the outer medulla, where a subset of thin descending limbs of loops of Henle expressed the transgene. This dynamic and developmentally regulated pattern indicates that Ang-2 is an early marker of the renal pericyte and vascular smooth muscle lineage and is also an epithelial-derived growth factor. Because Tie-2 is widely expressed by differentiating renal endothelia, this study is consistent with the hypothesis that Ang-2 has roles in kidney vascular maturation.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
There is growing interest in the cell lineage of the renal vasculature and in the molecules controlling its construction (1,2,3,4). Receptor tyrosine kinases (RTK) direct endothelial differentiation in diverse nonrenal vascular beds (5,6). The most investigated group includes vascular endothelial growth factor receptors (VEGFR), with VEGFR-2 initiating endothelial formation and VEGFR-1 modulating vessel assembly (5,6). Both are expressed by mouse renal mesenchyme on embryonic day 11.0 (E11.0) and by endothelia later in nephrogenesis (7,8,9). VEGF is expressed from the inception of murine metanephrogenesis (9), and functional experiments implicate this ligand in metanephric endothelial proliferation and glomerulogenesis (8,10,11).

Less is known about the Tie genes (tyrosine kinase containing immunoglobulin-like loops and epidermal growth factor similar domains), which constitute another class of endothelial RTK. As endothelia differentiate, the onset of Tie expression postdates VEGFR-2 but precedes maturity (5,6). Tie-1 null embryos die with impaired vessel integrity (12), and mutant cells in chimeras fail to contribute to renal vasculature, suggesting a nephrogenic role for this gene (13). Tie-1 is expressed in mouse metanephroi from E11.0 (9), with levels peaking in the first few weeks after birth (14). When avascular E11.0 Tie-1/LacZ metanephroi were implanted into wild-type neonatal kidneys (9), transgene-expressing glomerular and stromal capillaries developed in transplants, demonstrating in situ differentiation from Tie-1-positive precursors (9). Furthermore, Tie-1-expressing metanephric capillaries were upregulated in hypoxic organ culture (15). No ligand has been reported for Tie-1.

Tie-2 is a Tie-1 homologue and its ligands are encoded by angiopoietin (Ang) genes. Ang-1 binds Tie-2 eliciting tyrosine phosphorylation (16) and, although it does not stimulate endothelial proliferation (16), it prevents apoptosis (17) and causes sprouting in synergy with VEGF (18). Ang-1 (19) and Tie-2 (12,20) null mutant mouse embryos have abnormal vascular network formation with growth-retarded pericytes and vascular smooth muscle precursors. Folkman and D'Amore (21) postulated that Tie-2 signaling caused endothelial stabilization with reciprocal, maturational effects on pericytes elicited by endothelial-derived factors such as platelet-derived growth factor-B. Recent experiments show that Ang-1 is also a hematopoietic factor (22). Additional angiopoietins have been cloned (6,23,24). Ang-2 binds Tie-2 in cultured endothelia but does not cause tyrosine phosphorylation in these cells (23). Instead, it antagonizes Ang-1-induced Tie-2 phosphorylation, while Ang-2 overexpression in vivo causes defects resembling Tie-2 and Ang-1 null mutants (23).

Expression studies in nonrenal tissues are consistent with the hypothesis that Ang-1 and Ang-2 are expressed by smooth muscle cells, pericytes, and their precursors, and exert paracrine effects on Tie-2-expressing endothelia (16,23,25,26). However, certain endothelia can express Ang-2 in vitro (26,27), raising the additional possibility of an autocrine action. Ang-2 has also been implicated in hepatocellular carcinomas and glioblastoma growth (28,29), where it may facilitate sprouting by destabilizing existing capillaries, and in cycling ovarian follicles (23). The final effects of Ang-2 probably depend not only on the local expression of Ang-1 and Tie-2, but also on the activity of yet other factors such as VEGF (6,23).

In this study, we documented the nephrogenic pattern of Ang-2 in a mouse strain that expresses the LacZ reporter gene driven by the Ang-2 promoter. LacZ codes for bacterial ß-galactosidase, which is easily localized in tissues by the X-gal reaction (9,15). We demonstrate that Ang-2 is expressed at critical stages of renal vascular maturation, first by mesenchymal-derived endothelial support cells including pericytes, smooth muscle cells, and mesangial cells, and second by tubular epithelia near the maturing vasa rectae.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Reagents were obtained from Sigma Chemical Co. (St. Louis, MO) unless otherwise specified.

Ang-2/LacZ Mice
A promoterless LacZ gene and Ang-2 gene fragments were used to construct a targeting vector, which was introduced into embryonic stem cells to disrupt the Ang-2 gene (see Table 1 in reference (6) (C. Suri, J. McClain, M. V. Simmons, T. Sato, and G. D. Yancopoulos. manuscript in preparation), as described for Ang-1 null mutants (19). Positive clones were used to create chimeric mice by standard protocols (30). This resulted in mice in which the LacZ gene was driven by the Ang-2 promoter, i.e., Ang-2/LacZ mice. For the current experiments, Ang-2/LacZ heterozygous mice and wild-type littermates were generated by mating heterozygous males and females. Mice were genotyped by PCR using DNA extracted from embryo heads or postnatal tail snips (31). Primers were designed to amplify one mutated band (280 bp) or a wild-type band (380 bp), which were visualized after electrophoresis through ethidium bromide-stained agarose gels. The primers used were: 5'GDT: CTGGGATCTTGTCTTGGCC; mL2-intron1US1: CTTCTCTCTGTGACTGCTTTGC; and neo3'ds85: GAGATCAGCAGCCTCTGTTCC.


View this table:
[in this window]
[in a new window]

 
Table 1. LacZ expression driven by the Ang-2 promoter in mouse metanephrosa
 

PCR was performed for 30 cycles: 1 min denaturing at 95°C, 30 s annealing at 63°C, and 30 s extension at 72°C.

Mouse gestation lasts 21 d and the vaginal plug day was designated E0.0. Ages examined were E10.5, E12.0, E14.0, E19.0, the day of birth (neonatal), and 1, 3, and 8 wk postnatal (P1, P3, and P8). At least six animals (three wild-type and three heterozygous mice) were examined at each stage from at least two litters, and consistent results were reported. To count nephrons in neonatal and P3 mice (32), we incubated whole kidneys in hydrochloric acid for 10 to 50 min at 37°C, then rinsed them in tap water and stored them overnight at 4°C. Glomeruli were counted after mechanical dissociation.

X-Gal Staining
Metanephric and postnatal kidneys were fixed in 4% paraformaldehyde, 2 mM MgCl2, and 5 mM ethyleneglycol bis(ß-aminoethyl ether)-N,N'-tetra-acetic acid in phosphate-buffered saline (PBS) for 60 min at 4°C and washed 3 times in 1 x PBS. Staining was performed by incubation with 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 · 3H2O, 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% Nonidet P-40, and 1 mg/ml 4-chloro-5-bromo-3-indolyl-ß-D-galactopyranoside to allow optimal detection of cytoplasmic reporter gene product while abolishing background staining from endogenous galactosidase (9,15). Tissues were examined as whole mounts or were paraffin-embedded and sectioned at 10 µm. Sections were counterstained with hematoxylin, and some were subjected to immunohistochemistry, described below. Other tissues were processed for electron microscopy to visualize intracellular crystals produced by the X-gal reaction (33). Kidneys were fixed in 3% glutaraldehyde in pH 7.4 0.1 M sodium cacodylate and 5 mM NaCl. Ultrathin sections were cut on an RTC MT6000 ultramicrotome using a Diatome diamond knife (Agar Scientific Ltd., Stansted, United Kingdom). Sections were stained with 25% uranyl acetate in 50% methyl alcohol and Reynold's lead citrate, each for 20 min, and grids were examined with a JEOL 1200EX electron microscope (Tokyo, Japan). Other sections were examined without uranyl acetate because preliminary experiments revealed that X-gal reaction product crystals were visualized more easily in this manner, albeit with some loss of tissue definition.

Immunohistochemistry
Paraffin sections were treated with trypsin (1 mg/ml) for 10 min at 37°C. Endogenous peroxidase was quenched with 3% H2O2 in methanol for 30 min at room temperature, and sections were blocked in 10% goat serum with 0.1% Tween 20. They were reacted with an alkaline phosphatase-conjugated antibody to {alpha}-smooth muscle actin ({alpha}-SMA) (1:100; Sigma; A-5691) or a horseradish peroxidase-conjugated antibody to anti-{alpha}-SMA (1:100; DAKO; U7033), a vascular wall marker (34); an antibody to aquaporin-1 (a gift from Mark A. Knepper, National Institutes of Health, Bethesda, MD), a marker of a subset of thin descending limbs of loops of Henle and descending vasa recta (35); and an antibody to Tamm-Horsfall glycoprotein (1:50; Europa Bioproducts Ltd., Cambridge, United Kingdom), a marker of thick ascending limbs of loops of Henle (36). Bound aquaporin-1 and Tamm-Horsfall glycoprotein antibodies were detected with the streptavidin-biotin peroxidase ABC kit (DAKO, High Wycombe, United Kingdom), producing a brown product. For {alpha}-SMA, we used either Fast Red for the Sigma antibody or diaminobenzidine for the DAKO antibody. Both gave essentially similar results apart from the vasa recta area, where only the peroxidase technique was sensitive enough to detect {alpha}-SMA immunoreactivity in the pericytes of the descending vasa recta.

Statistical Analyses
Results are given as mean ± SD. Group means were compared using the t test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
The mouse metanephros begins to form on E10.5 when the ureteric bud branches from the mesonephric duct toward an avascular area of intermediate mesoderm, the renal mesenchyme (1). At this time, the mesonephric kidneys are more developed and contain tubules and capillaries. By E12.0, the ureteric bud has branched a few times and a capillary network appears between metanephric epithelia (1). The first metanephric glomeruli form by E14.0, and new layers of nephrons are generated to P1 (1). In contrast, medullary differentiation is most marked in the 3 wk after birth (14). We therefore described results in three stages: E10.5 to E14.0 (early nephrogenesis), E19.0 to P1 (late nephrogenesis), and P3 to P8 (postnatal maturity). Table 1 shows an overview of transgene expression.

Early Nephrogenesis
During E10.5 to 14.0, no X-gal staining was observed in wild-type embryos (not shown). Furthermore, the timing and anatomy of early nephrogenesis appeared similar in wild-type and heterozygous littermates, although this was not quantified. Figure 1A is a whole mount of an E10.5 Ang-2/LacZ heterozygous embryo with transgene expression in cardiac outflow tract, liver primordium, dorsal aorta, and allantoic region. Histology confirmed that liver cells were positive (Figure 1B). At E10.5, the mesonephros contained capillaries and tubules but did not express the transgene (Figure 1C), nor did the avascular metanephric primordium (not shown). The E12.0 metanephros contained patent capillaries around ureteric bud branches but no Ang-2/LacZ expression was detected in heterozygous organs (Figure 1D). At E14.0, metanephric Ang-2/LacZ expression was detected in whole mounts (Figure 1E); dorsal aorta and adrenal glands were also positive. Histology (Figure 1F) demonstrated transgene expression around aorta, renal artery, and its first-order metanephric branches. A high-power view of the dorsal aorta (Figure 1G) demonstrated multiple layers of Ang-2/LacZ-expressing cells around the lumen. Transgene expression tended to be more extensive than for {alpha}-SMA, which was confined to cells near the endothelium (Figure 1, compare H and G). There was a compact arrangement of X-gal-positive cells around the renal artery and its intrarenal branches (Figure 1I). Endothelial cells in the dorsal aorta expressed Ang-2/LacZ (Figure 1, G and H), whereas those in renal artery branches were negative (Figure 1H). The first metanephric glomeruli formed by E14.0 and were X-gal-negative (Figure 1J).



View larger version (88K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Angiopoietin-2 (Ang-2)/LacZ expression in early nephrogenesis in heterozygous mice. X-gal staining appeared as a cytoplasmic, light blue color. B through D and F through J were stained with hematoxylin. H was also immunostained for {alpha}-smooth muscle actin ({alpha}-SMA). (A) Embryonic day 10.5 (E10.5) whole mount embryo with forelimb removed demonstrated Ang-2/LacZ expression in cardiac outflow tract (a), liver (b), dorsal aorta (c), and allantois (d). (B) Histology of E10.5 liver. (C) E10.5 mesonephros contained tubules (t) and capillaries (c), which did not express Ang-2/LacZ. (D) E12.0 metanephros contained capillaries (c) around ureteric bud branches (u) and was X-gal-negative. (E) Whole mount of E14.0 abdominal cavity where aorta (a), adrenal glands (b), and metanephroi (c) expressed the transgene. (F) Ang-2/LacZ expression in E14.0 aorta (a), metanephric artery (b), and its branches (c). (G) Multiple layers of transgene-expressing cells in wall of E14.0 aorta. Aortic endothelia also expressed Ang-2/LacZ and some had collapsed into the lumen during processing. (H) As for G, with {alpha}-SMA immunostaining (red). (I) Transgene-expressing cells in wall of a branch of the E14.0 metanephric artery; its endothelia (arrowheads) did not express Ang-2/LacZ. (J) E14.0 metanephric glomeruli did not express Ang-2/LacZ. Bars: 8 µm in B through D and G through I; 24 µm in F.

 

Late Nephrogenesis
At E19.0 and in neonatal kidneys, a similar and complex pattern of Ang-2/LacZ transgene expression was found. Wild-type control kidneys showed no X-gal staining and were of similar size to heterozygous littermates (Figure 2A). Neither kidney weights nor numbers of glomeruli showed any significant difference between the two groups on the first day after birth (Table 2). In whole mounts of heterozygous kidneys, the transgene was expressed in renal artery branches, extending to third- and fourth-order vessels (Figure 2, A through C). Sectioning whole mounts allowed visualization of Ang-2/LacZ expression in arcuate vessels at the junction of cortex and medulla (Figure 2, D and E). Figure 3, A through C, shows micrographs of heterozygous neonatal kidneys reacted with X-gal and immunostained for {alpha}-SMA. Glomeruli expressed the transgene in the hilum and the mesangium (Figure 3, A and G). Weak Ang-2/LacZ expression was also noted in a few cells in the terminal portions of proximal tubules and descending thin limbs of loops of Henle (Figure 3B), and thinner, parallel medullary structures considered to be small vessels (Figure 3C). These organs expressed {alpha}-SMA in small cortical arteries (Figure 3A), afferent glomerular arterioles (not shown), and in a ladder arrangement of stromal cells between medullary structures (Figure 3, B and C). Figure 3, D through F, shows comparable areas of wild-type littermate kidneys demonstrating absent X-gal staining in diverse structures that were morphologically similar to those in heterozygous organs; patterns of {alpha}-SMA were also similar. Heterozygous arcuate vessels (Figure 3G) expressed Ang-2/LacZ in multiple layers of wall cells enveloping endothelia. However, not all cells in a vessel were positive, even though situated at a similar radial distance from the endothelium (Figure 3G). Transgene expression in small cortical and arcuate (Figure 3H) arteries extended further outward than {alpha}-SMA immunostaining, even when the more sensitive peroxidase technique was used for immunodetection.



View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Whole mount X-gal staining in late nephrogenesis. All preparations were stained with X-gal. (A) Low-power view of wild-type metanephros (left) and an Ang-2/LacZ heterozygous littermate (right). The former was unreactive with X-gal, whereas the latter was positive. Note similar sizes of the organs. B and C show intermediate and higher-power views of a heterozygous organ with Ang-2/LacZ expression extending to third and fourth order renal artery branches. D and E show intermediate and higher-power views of sectioned heterozygous organs. Transgene-expressing arcuate vessels (letter a in E) at the border of the cortex and medulla, and small cortical vessels were visualized (letter x in E). (F) Whole mount of postnatal week 1 (P1) organ sectioned through the middle of the kidney. Note clusters of transgene-expressing juxtamedullary glomeruli (arrowheads) and arrays of fine structures aligned to the longitudinal axis of the medulla. (G) High power view of F.

 

View this table:
[in this window]
[in a new window]

 
Table 2. Kidney weights and nephron numbersa
 


View larger version (120K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Histology in late nephrogenesis. A through H were neonatal kidneys and I was a P1 organ. A through C and G through I were heterozygous organs, whereas D through E were wild type. All sections were stained with hematoxylin and X-gal. A through F were also probed for {alpha}-SMA detected by Fast Red and H by the immunoperoxidase technique. (A) {alpha}-SMA protein in a small cortical artery in a heterozygous organ. Note Ang-2/LacZ expression in the hilum and mesangial area of a glomerulus. (B) In same organ as A, there was weak transgene expression in a few cells (arrowheads) in the terminal portion of a proximal tubule and the descending thin limb of the loop of Henle surrounded by a network of {alpha}-SMA-positive stromal cells. (C) Ang-2/LacZ expression in the outer medulla in a small vessel surrounded by a network of {alpha}-SMA-positive stromal cells. D through F represent matching views of A through C but in a wild-type littermate. Note absent X-gal staining in structures, morphologically similar to the heterozygous kidney. (G) Arcuate artery (a) in a heterozygous kidney with transgene expression in multilayers of cells, presumed to be differentiating pericytes and smooth muscle cells: Note that some cells (arrowheads) expressed higher levels of the transgene. The arterial endothelium was negative. The mesangial area of a juxtamedullary glomerulus (g) also expressed Ang-2/LacZ. An adjacent arcuate vein is shown (v). (H) Ang-2/LacZ-expressing cells (in blue; large arrowheads) extended further out from the wall of an arcuate artery (a) and its branches than immunostaining for {alpha}-SMA (brown). Note that endothelia (small arrowheads) were negative for transgene and {alpha}-SMA expression. (I) Cross section through the outer medulla of a P1 organ demonstrates two types of X-gal-positive structure: thin-walled profiles, presumed to be vessels (small arrowheads), and profiles with thicker walls (large arrowheads), which were presumed to be a variety of tubule. Bars, 8 µm.

 

One week after birth, heterozygous kidneys exhibited prominent medullary Ang-2/LacZ expression in thin structures aligned radially in the medulla (Figure 2F). Histology revealed two types of X-gal-positive elements (Figure 3I): thin structures, presumed to be vessels, and thicker epithelial structures that may be loops of Henle. Clusters of transgene-expressing "dots" were noted in the deep cortex (Figure 2, F and G), and histology demonstrated that these were juxtamedullary glomeruli and smaller vessels (not shown).

Postnatal Maturity
By 3 wk after birth, the kidney had matured, glomerulogenesis having ended between P1 and P2 and the vasa recta bundles having reached their adult conformation. Organs of wild-type P3 kidneys were of similar weight and contained similar numbers of glomeruli as heterozygous littermates (Table 2). Wild-type organs were negative after X-gal staining (Figure 4A). In whole mounts of heterozygous P3 organs, intense Ang-2/LacZ expression was noted in bundles of structures in the inner part of the outer medulla (Figure 4B). These organs also expressed the transgene in large branches of the renal artery (not shown) and in arcuate, smaller cortical and afferent vessels supplying deep glomeruli (Figure 4C). In P8 whole mounts (Figure 4D), there was downregulated transgene expression in cortex and inner medulla, whereas Ang-2/LacZ expression near vasa rectae remained prominent.



View larger version (82K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Whole mount X-gal staining in postnatal maturity. All tissues were reacted with X-gal.(A) Wild-type P3 kidney showed no X-gal staining. (B) Heterozygous P3 kidney sectioned through the medulla. Note transgene expression in bundles in the outer medulla with weaker expression in cortical and deep medullary structures. (C) High-power heterozygous organ whole mount looking down on the deep cortex. A deep branch of the main renal artery is obscured in this view but has branched at point x into arcuate (a) and smaller cortical vessels, giving rise to fine afferent arterioles (arrowheads) supplying glomeruli that also express Ang-2/LacZ (arrows). (D) P8 kidney demonstrates persistent transgene expression in outer medulla with diminished expression elsewhere.

 

Figure 5 shows histology at P3. In heterozygous kidneys, Ang-2/LacZ expression was downregulated in glomeruli versus neonates and P1, with no expression in outer cortical glomeruli (Figure 5A), and low expression in juxtamedullary glomeruli (not shown). In contrast, there was intense Ang-2/LacZ expression in the inner stripe of the outer medulla (Figure 5, A, C, E, and G). Figure 5, B, D, F, and H are complementary views of wild-type littermates: They were X-gal-negative and structurally similar to heterozygous kidneys. Histology with counterstaining for {alpha}-SMA, aquaporin-1, and Tamm-Horsfall glycoprotein clarified that the most prominent transgene-expressing structures were located near vasa recta bundles and were discrete from: (1) {alpha}-SMA-positive pericytes in descending vasa rectae (Figure 5C); (2) aquaporin-1-positive thin descending limbs (Figure 5E); and (3) Tamm-Horsfall glycoprotein-positive thick ascending limbs of loops of Henle (Figure 5G). Two points should be noted here. First, in murine species, a subset of thin descending limbs of loops of Henle, derived from short-looped nephrons, are intimately associated with vasa recta bundles (37). Second, thin descending limbs are heterogeneous with respect to aquaporin-1 expression, with short nephrons expressing little or no aquaporin-1 (35). Hence, our data were consistent with Ang-2/LacZ expression in this subset of thin descending limbs.



View larger version (123K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. Histology in postnatal maturity. All sections were stained with hematoxylin and X-gal. A and B were also immunostained for {alpha}-SMA detected by Fast Red and C by the peroxidase technique. A, C, E, and G were heterozygous Ang-2/LacZ organs, and B, D, F, and H were wild-type littermates. (A) Low-power view showed bundles of transgene expression in outer medulla. (B) Wild-type kidney. (C) High power of longitudinal section of vasa recta bundle area with thick transgene-expressing tubules (large arrowheads) and thin structures positive for {alpha}-SMA, which most likely are descending vasa rectae pericytes (small arrowheads). (D) Wild-type kidney at comparable level to C, stained with X-gal. (E) Transverse section of outer medulla immunostained for aquaporin-1. Transgene-expressing profiles were distinct from brown immunostained descending thin limbs of loops of Henle (large arrowheads) and smaller structures, which are most likely descending vasa rectae (small arrowheads). (F) Wild-type kidney stained with aquaporin-1 antibody. (G) Similar section as E, but immunostained for Tamm-Horsfall glycoprotein. Transgene-expressing structures were distinct from immunostained thick ascending limbs of loops of Henle (brown). (H) Wild-type littermate stained for Tamm-Horsfall glycoprotein. Bars: 80 µm in A and B; 8 µm in C through H.

 

Electron microscopy of wild-type (not shown) and heterozygous mice showed four profiles in this location (Figure 6A) (37): tubules with a thin layer of light cytoplasm and sparse microvilli, which were thin descending limbs of loops of Henle; tubules with a thick layer of mitochondria-rich cytoplasm, which were thick ascending limbs; fenestrated endothelia with wide lumens, which were ascending vasa rectae; and nonfenestrated endothelia, which were descending vasa rectae. X-gal staining of heterozygous organs revealed cytoplasmic precipitation of reaction product crystals in thin descending limbs of loops of Henle: These crystals were more easily seen in sections in which uranyl acetate staining had been omitted, as shown in Figure 6B.



View larger version (127K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 6. Electron microscopy of vasa rectae bundle area. Electron microscopy of vasa recta bundle area in outer medulla at P3. (A) Heterozygous kidney, unstained with X-gal but stained with uranyl acetate, shows tubules with a relatively thin layer of light cytoplasm and sparse microvilli (arrowheads), which are thin descending limbs of loops of Henle (a), vasa recta capillaries (b), and tubules with a thick layer of mitochondria-rich cytoplasm, which are thick ascending limbs of loops of Henle (c). (B) Similar area from heterozygous mouse, unstained with uranyl acetate, but stained with X-gal with reaction product crystals (small arrowheads) in a thin descending limb of loop of Henle (a) characterized by microvilli (large arrowheads). An adjacent capillary is also shown (b). Bars: 1 µm in A; 0.5 µm in B.

 


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Recently, Yuan et al. (14) studied Ang-1, Ang-2, and Tie-2 expression from the onset of glomerulogenesis (E14.0) to adulthood in wild-type mice. Using Northern blotting, the genes were expressed through this period with peak levels at P2 to P3. Using Western blotting, Tie-2 was detected from E14.0, with tyrosine-phosphorylated RTK evident from E18.0. By in situ hybridization and immunohistochemistry, Tie-2 was localized to capillaries in nephrogenic cortex, glomerular tufts, and vasa rectae. By in situ hybridization, Ang-1 transcripts were found in condensing cortical mesenchyme, maturing glomeruli, proximal tubules, and outer medullary tubules.

Yuan et al. (14) also localized Ang-2 mRNA to maturing outer medulla with a maximal signal at P3 in vasa rectae in the inner stripe. However, the resolution of the in situ hybridization technique was not optimal for the definitive assignment of Ang-2-expressing cells because of tissue distortion caused by the rigorous preparation required by this method. Furthermore, the relatively low sensitivity of the nonradioactive in situ technique probably only detected cells with the highest levels of Ang-2 transcripts. We therefore used heterozygous Ang-2/LacZ mice to further define Ang-2 expression during kidney development.

The results of our current study are consistent with several previous observations (14), including: (1) upregulation of metanephric Ang-2 expression prenatally; (2) intense expression of Ang-2 in postnatal outer medulla; and (3) an overall decreased expression between P3 and P8. It is important to note that heterozygous Ang-2/LacZ kidneys underwent normal development, as assessed by the acquisition of glomeruli and complex structures such as vasa rectae. Our new data further define the nature of Ang-2-expressing cells in the outer medulla and also demonstrate Ang-2 promoter activity in renal vasculature and glomeruli. These aspects are now discussed.

Ang-2 in Developing Renal Vessels
Hungerford and Little (38) have reviewed the ontogeny of vascular smooth muscle, which differentiates as "fibroblast-like" cells, lacking myofilaments and basement membranes and appearing as aggregates near embryonic endothelium. In avian embryos, where lineage studies have been performed, aortic arch vascular smooth muscle cells derive from neural crest (i.e., ectoderm), whereas vascular smooth muscle in the rest of the embryo may originate from mesoderm. An alternative view was proposed by DeRuiter et al. (39), who showed that embryonic avian endothelia from dorsal aorta could transdifferentiate into mesenchymal cells, which expressed myofilaments. Once recruited into the lineage, vessel wall precursors express marker proteins for smooth muscle maturation, with the highest levels near the endothelial layer. One such protein is heavy caldesmon (40), although this has not been examined in nephrogenesis. Another structural protein expressed in this lineage is {alpha}-SMA, which constitutes up 40% of total protein in mature cells, and Carey et al. (34) reported that it was widely expressed in the developing rat renal vasculature.

Simple capillaries in the E12.0 metanephros did not express Ang-2/LacZ but, at E14.0, the transgene was expressed in multiple layers of cells surrounding endothelia of the renal artery and its branches. As nephrogenesis proceeded, expression was maintained in the arterial tree, extending to the arcuate and small cortical vessels. Based on this dynamic and developmentally regulated pattern, we propose that Ang-2 is a marker for the renal vascular smooth muscle lineage. Not all cells in a single locus in an arterial wall expressed Ang-2/LacZ, even though situated at a similar distance from the endothelium. This heterogeneity might be explained by the presence of smooth muscle cells of varied maturity, as discussed by Ehler et al. (41). Using double labeling for {alpha}-SMA and Ang-2/LacZ, we found that myofilament immunolocalized to cells adjacent to arterial endothelia, whereas Ang-2 expression tended to extend to loosely arranged peripheral cells. However, we cannot rule out weak expression of {alpha}-SMA in peripheral cells, which might only be detectable by a more sensitive method.

Hence, if vascular smooth muscle cells are recruited from surrounding mesenchyme, Ang-2 may be a very early lineage marker. However, from our descriptive study alone, it is impossible to know whether all such Ang-2-positive cells will be incorporated into vessel walls, and it is also possible that some will die or become interstitial cells. Although we noted weak transgene expression in small medullary vessels in the first postnatal week, it was not possible to establish whether this signal originated in endothelial or enveloping cells.

Of note, the walls of the developing kidney vasculature show widespread expression of another secreted protein, renin (42). However, although we found that Ang-2 expression was continuous through the fetal kidney arterial system to the level of small cortical arteries, albeit not in every cell in a single locus, renin-expressing cells were reported to be discontinuous, for example, localized to nascent branch points (42). Interestingly, it was recently reported that aquaporin-1 immunolocalized to the developing rat renal vasculature in a broadly similar pattern to Ang-2 (43), although it was not fully established which cells (i.e., endothelial or pericyte/smooth muscle) expressed the water pore. Collectively, these studies demonstrate a spectrum of gene expression in the renal vasculature, which is dramatically developmentally regulated.

Ang-2 Expression in Glomeruli
Our study further shows that Ang-2/LacZ was expressed in the core of developing glomeruli, most likely in the mesangium. Mesangial cells share biosynthetic and structural properties with vascular smooth muscle cells (44), and Ang-2 expression is therefore consistent with this relationship. Our unpublished data (H. T. Yuan and A. S. Woolf, personal observations) show that conditionally immortal mesangial cell lines isolated from young mice (45) express Ang-2 mRNA in culture. The origin of mesangial cells is unknown, although they appear to derive from endogenous precursors in the metanephros (46) and their formation is dependent on platelet-derived growth factor-B (47,48). We speculate that Ang-2 from developing mesangial cells modulates the growth of adjacent endothelia, which themselves express Tie-2 (14). In this context, it is of interest that cultured mesangial cells express other secreted factors that can target endothelia. These include VEGF (49) and hepatocyte growth factor (45,50).

Ang-2 Expression and the Vasa Recta
We found low levels of Ang-2/LacZ expression in proximal tubules and thin descending limbs of loops of Henle in the neonatal period, consistent with our previous in situ hybridization data (14). In the same study, Yuan et al. (14) reported a strong in situ hybridization in outer medullary vasa recta bundles at P3, by which time these structures have acquired a mature configuration. However, the resolution of that technique did not allow the definitive assignment of positive cells. Our current analysis of the outer medulla in P3 heterozygous Ang-2/LacZ kidneys demonstrated prominent transgene expression in tubular structures incorporated into the vasa recta bundle. Based on reasoning outlined in the Results section, we suggest that these represent a subset of thin descending limbs of loops of Henle, which are aquaporin-1-negative and are derived from short-looped nephrons. We are aware that Park et al. (51) reported that pericytes envelop descending vasa rectae and, mindful of our observation that Ang-2 is expressed by this lineage elsewhere in the kidney, we cannot exclude the possibility that these cells also express Ang-2 below the current limit of detection.


    Conclusion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
We first propose that Ang-2 protein is secreted by vascular wall cells during kidney development, where it would cause paracrine modulation of Ang-1-induced activation of Tie-2 RTK in nearby endothelial cells. Second, Ang-2 expressed within glomeruli may affect the maturation of glomerular capillary loops, and immature glomeruli are known sites of Ang-1 expression (14). In contrast, vascular maturation in the outer medulla may be primarily modulated by Ang-2 secreted from epithelia rather than from the smooth muscle lineage. In fact, as Ang-2 transcripts and Ang-2/LacZ expression are upregulated in this location in the first few postnatal weeks, the Ang-1 mRNA in situ signal decreases (14), observations consistent with the hypothesis that Ang-2 terminates capillary maturation stimulated by Ang-1. Certainly, Tie-2 is widely expressed in endothelia during nephrogenesis (14), but formal proof for a role of Ang-2 demands functional as well as descriptive experiments. Currently, we are analyzing kidneys from null Ang-2 mice to address these questions.


    Acknowledgments
 
This work was supported by the Kidney Research Aid Fund and Wellcome Trust Project Grant 058005. We thank Brian Young (Institute of Neurology, University College London Medical School, London, United Kingdom) for assistance with electron microscopy and Mark A. Knepper (Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD) for the kind gift of the aquaporin-1 antibody.


    Footnotes
 
Journal of the American Society of Nephrology


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 

  1. Loughna S, Landels E, Woolf AS: Growth factor control of developing kidney endothelial cells. Exp Nephrol4 : 112-118,1996[Medline]
  2. Gomez RA, Norwood VF, Tufro-McReddie A: Development of the kidney vasculature. Microsc Res Tech39 : 254-260,1997[Medline]
  3. Woolf AS, Loughna S: Origin of glomerular capillaries: Is the verdict in? Exp Nephrol 6:17 -21, 1998[Medline]
  4. Abrahamson DR, Robert B, Hyink DP, St. John PL, Daniel TO: Origins and formation of microvasculature in the developing kidney. Kidney Int Suppl 67:S7 -S11, 1998[Medline]
  5. Risau W: Mechanisms of angiogenesis. Nature387 : 671-674,1997
  6. Gale NW, Yancopoulos GD: Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev13 : 1055-1066,1999[Free Full Text]
  7. Robert B, St. John PL, Hyink DP, Abrahamson DR: Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. Am J Physiol 271:F744 -F753, 1996[Abstract/Free Full Text]
  8. Tufro-McReddie A, Norwood VF, Aylor KW, Botkin SJ, Carey RM, Gomez RA: Oxygen regulates vascular endothelial growth factor-mediated vasculogenesis and tubulogenesis. Dev Biol183 : 139-149,1997[Medline]
  9. Loughna S, Hardman P, Landels E, Jussila L, Alitalo K, Woolf AS: A molecular and genetic analysis of renal glomerular capillary development. Angiogenesis 1:84 -101, 1997
  10. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest99 : 2351-2357,1997[Medline]
  11. Gerber H-P, Hillan KJ, Ryan AM, Kowalski J, Keller G-A, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N: VEGF is required for growth and survival in neonatal mice. Development126 : 1149-1159,1999[Abstract]
  12. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70 -74, 1995[Medline]
  13. Partanen J, Puri MC, Schwartz L, Fischer KD, Bernstein A, Rossant J: Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development122 : 3013-3021,1996[Abstract]
  14. Yuan HT, Suri C, Yancopoulos GD, Woolf AS: Expression of angiopoietin-1, angiopoietin-2 and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. J Am Soc Nephrol10 : 1722-1736,1999[Abstract/Free Full Text]
  15. Loughna S, Yuan HT, Woolf AS: Effects of oxygen on vascular patterning in Tie1/LacZ metanephric kidneys in vitro. Biochem Biophys Res Commun 247:361 -366, 1998[Medline]
  16. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion trap expression cloning. Cell 87:1161 -1170, 1996[Medline]
  17. Papapetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, Sessa WC: Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival and interaction with other angiogenic growth factors. Lab Invest79 : 213-223,1999[Medline]
  18. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W: Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8: 529-532,1998[Medline]
  19. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell87 : 1171-1180,1996[Medline]
  20. Dumont DJ, Gradwohl G, Fong G-H, Puri MC, Gerstenstein M, Auerbach A, Breitman ML: Dominant-negative and targeted null-mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev8 : 1897-1909,1994[Abstract/Free Full Text]
  21. Folkman J, D'Amore PA: Blood vessel formation: What is its molecular basis? Cell 87:11153 -1155, 1996
  22. Takakura N, Huang XL, Naruse T, Hamguchi I, Dumont DJ, Yancopoulos GD, Suda T: Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity9 : 677-686,1998[Medline]
  23. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angio-poietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science277 : 55-60,1997[Abstract/Free Full Text]
  24. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H, McClain J, Copeland NG, Gilbert DJ, Jenkins NA, Huang T, Papadopoulos N, Maisonpierre PC, Davis S, Yancopoulos GD: Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96:1904 -1909, 1999[Abstract/Free Full Text]
  25. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM: Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514 -18521, 1998[Abstract/Free Full Text]
  26. Mandriota SJ, Pepper MS: Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 19:852 -859, 1998
  27. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y: Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem274 : 15732-15739,1999[Abstract/Free Full Text]
  28. Stratmann A, Risau W, Plate KH: Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153:1459 -1466, 1998[Abstract/Free Full Text]
  29. Tanaka S, Mori M, Sakamoto Y, Makuuchi M, Sugimachi K, Wands JR: Biological significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest 103:341 -345, 1999[Medline]
  30. DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ, Yancopoulos GD: The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell85 : 501-512,1996[Medline]
  31. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
  32. Lelievre-Pegorier M, Vilar J, Ferrier M-L, Moreau E, Freund N, Gilbert T, Merlet-Benichou C: Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int54 : 1455-1462,1998[Medline]
  33. Synder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg EA, Cepko CL: Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33 -51, 1992[Medline]
  34. Carey AV, Carey RM, Gomez RA: Expression of alpha-smooth muscle actin in the developing kidney vasculature. Hypertension 19[2 Suppl]:II168 -II175, 1992
  35. Nielsen S, Pallone T, Smith BL, Christensen EI, Agre P, Maunsbach AB: Aquaporin-1 water channels in short and long loop descending thin limbs and in descending vasa recta in rat kidney. Am J Physiol 268:F1023 -F1037, 1995[Abstract/Free Full Text]
  36. Hoyer JR, Resnick JS, Michael AF, Vernier RL: Ontogeny of Tamm-Horsfall urinary glycoprotein. Lab Invest30 : 757-761,1974[Medline]
  37. Tisher CC, Madsen KM: Anatomy of the kidney. In: The Kidney, 5th Ed., edited by Brenner BM, Philadelphia, Saunders,1996 , pp 3-71
  38. Hungerford JE, Little CD: Developmental biology of the vascular smooth muscle cell: Building a multilayered vessel wall. J Vasc Res 36: 2-27,1999[Medline]
  39. DeRuiter MC, Poelmann RE, Van Munsteren JC, Mironov V, Markwald RR, Gitternberger-de Groot AC: Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 80:444 -451, 1997[Abstract/Free Full Text]
  40. Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA: Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponin. Dev Biol153 : 185-193,1992[Medline]
  41. Ehler E, Jat PS, Noble MD, Citi S, Draeger A: Vascular smooth muscle cells of H-2Kb-tsA58 transgenic mice: Characterisation of cell lines with distinct properties. Circulation92 : 3289-3296,1995[Abstract/Free Full Text]
  42. Reddi V, Zaglul A, Pentz ES, Gomez RA: Renin-expressing cells are associated with branching of the developing kidney vasculature. J Am Soc Nephrol 9:63 -71, 1998[Abstract]
  43. Kim J, Kim WY, Han KH, Knepper MA, Nielsen S, Madsen KM: Developmental expression of aquaporin 1 in the rat renal vasculature. Am J Physiol 276:F498 -F509, 1999[Abstract/Free Full Text]
  44. Dubey RK, Jackson EK, Rupprecht HD, Sterzel RB: Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens6 : 88-105,1997[Medline]
  45. Kolatsi-Joannou M, Woolf AS, Hardman P, Gordge M, White SJ, Henderson R: The hepatocyte growth factor/scatter factor receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells. J Cell Sci108 : 3703-3714,1995[Abstract]
  46. Hyink DP, Tucker DC, St. John PL, Leardkamolkarn V, Accavitti MA, Abrass CK, Abrahamson DR: Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneys. Am J Physiol 270:F886 -F899, 1996[Abstract/Free Full Text]
  47. Soriano P: Abnormal kidney development and hematological disorders in platelet derived growth factor ß-receptor mutant mice. Genes Dev 8:1888 -1896, 1994[Abstract/Free Full Text]
  48. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF: Developmental patterns of PFGF B-chain, PDGF-receptor, and {alpha}-actin expression in human glomerulogenesis. Kidney Int42 : 390-399,1992[Medline]
  49. Gruden G, Thomas S, Burt D, Zhou W, Chusney G, Gnudi L, Viberti G: Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol 10:730 -737, 1999[Abstract/Free Full Text]
  50. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA90 : 1937-1941,1993[Abstract/Free Full Text]
  51. Park F, Mattson DL, Roberts LA, Cowley AW Jr: Evidence for the presence of smooth muscle alpha-actin within pericytes of the renal medulla. Am J Physiol 273:R1742 -R1748, 1997[Abstract/Free Full Text]
Received for publication August 12, 1999. Accepted for publication October 12, 1999.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
B. Davis, A. Dei Cas, D. A. Long, K. E. White, A. Hayward, C.-H. Ku, A. S. Woolf, R. Bilous, G. Viberti, and L. Gnudi
Podocyte-Specific Expression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2320 - 2329.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. P. de Caestecker
Angiopoietin-2 and Glomerular Proteinuria
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2217 - 2218.
[Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Matsui, M. Kanai-Azuma, K. Hara, S. Matoba, R. Hiramatsu, H. Kawakami, M. Kurohmaru, P. Koopman, and Y. Kanai
Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice
J. Cell Sci., September 1, 2006; 119(17): 3513 - 3526.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. E. Pitera, A. S. Woolf, N. W. Gale, G. D. Yancopoulos, and H. T. Yuan
Dysmorphogenesis of Kidney Cortical Peritubular Capillaries in Angiopoietin-2-Deficient Mice
Am. J. Pathol., December 1, 2004; 165(6): 1895 - 1906.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Rizkalla, J. M. Forbes, M. E. Cooper, and Z. Cao
Increased Renal Vascular Endothelial Growth Factor and Angiopoietins by Angiotensin II Infusion Is Mediated by Both AT1 and AT2 Receptors
J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3061 - 3071.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. B. Freeburg, B. Robert, P. L. St. John, and D. R. Abrahamson
Podocyte Expression of Hypoxia-Inducible Factor (HIF)-1 and HIF-2 during Glomerular Development
J. Am. Soc. Nephrol., April 1, 2003; 14(4): 927 - 938.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. Pavenstadt, W. Kriz, and M. Kretzler
Cell Biology of the Glomerular Podocyte
Physiol Rev, January 1, 2003; 83(1): 253 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. C. Satchell, S. J. Harper, J. E. Tooke, D. Kerjaschki, M. A. Saleem, and P. W. Mathieson
Human Podocytes Express Angiopoietin 1, a Potential Regulator of Glomerular Vascular Endothelial Growth Factor
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 544 - 550.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Takahashi, K. Takahashi, S. Gerety, H. Wang, D. J. Anderson, and T. O. Daniel
Temporally Compartmentalized Expression of Ephrin-B2 during Renal Glomerular Development
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2673 - 2682.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. A. Long, A. S. Woolf, T. Suda, and H. T. Yuan
Increased Renal Angiopoietin-1 Expression in Folic Acid-Induced Nephrotoxicity in Mice
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2721 - 2731.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YUAN, H. T.
Right arrow Articles by WOOLF, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YUAN, H. T.
Right arrow Articles by WOOLF, A. S.


HOME CURRENT ISSUE